drugset / Trial / NCT04810676
A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383.
RandomizedCrossoverOpen-labelTreatment
Summary
A clinical trial to evaluate the pharmacokinetic profiles and safety of CKD-383.
Timeline
- Start
- 2021-04-16
- Primary completion
- 2021-05-20
- Completion
- 2021-05-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CKD-383 | Unknown | — | Oral |
| Subject | D150 | Unknown | — | Oral |
| Subject | D745 | Unknown | — | Oral |
| Subject | Lobeglitazone | Small molecule | — | Oral |